Litigation involving US Patent 11021737

11021737

Cases

Active

1 closed

Filed

2022–2026

Top venue

D. Delaware

3 cases

Filing activity

Cases asserting US Patent 11021737 filed per year.

10x Genomics, Inc. et al. v. Element Biosciences, Inc.

pending

Court:: U.S. District Court for the District of Delaware
Filed:: 2026-05-08

Patents:12264358 11021737 11566276 11566277

π 10x Genomics, Inc.π President and Fellows of Harvard College (Harvard University)Δ Element Biosciences, Inc.

The lawsuit alleges that Element Biosciences' AVITI24 platform and Teton chemistry infringe upon the asserted patents. The plaintiffs seek a permanent injunction, ongoing royalties, and damages for past infringement.

10x Genomics, Inc. et al. v. Vizgen, Inc.

Settled

Docket:: 1:22-cv-00595
Court:: U.S. District Court for the District of Delaware
Filed:: 2022-05-04

Patents:11021737

π 10x Genomics, Inc.π President and Fellows of Harvard College Δ Vizgen, Inc.

This case involved infringement claims by 10x and Harvard, with Vizgen filing counterclaims for non-infringement, invalidity, and antitrust violations. The parties reached a settlement in early February 2025, resolving the global patent dispute.

10x Genomics, Inc. et al. v. NanoString Technologies, Inc.

Active

Docket:: 1:22-cv-00261
Court:: U.S. District Court for the District of Delaware
Filed:: 2022-02-28

Patents:11021737

π 10x Genomics, Inc.π President and Fellows of Harvard College Δ NanoString Technologies, Inc.

This case involves a broader dispute over multiple spatial technology patents, including US 11,021,737. The case is ongoing, with proceedings previously linked to the related action against Vizgen.